Genuine question, there are a lot of overly ambitious efforts like, even though this seems the most ambitious of them all - but is this all optimistic investment or is there any iota of indication that this is a viable path? I am very skeptical of the ai initiatives in medicine and biology where they want to solve problems that humans cannot yet. I would love to be wrong of course
Is this an investment that disease and genetics researchers believe will be valuable?
Or is this primarily tax deductible funds flowing back into the AI industrial complex?
(Honest question! If it’s a truly promising path that’s great)